207 related articles for article (PubMed ID: 21689156)
1. Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in tumor-bearing dogs.
Skorupski KA; Hammond GM; Irish AM; Kent MS; Guerrero TA; Rodriguez CO; Griffin DW
J Vet Intern Med; 2011; 25(4):838-45. PubMed ID: 21689156
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)*.
Hosoya K; Lord LK; Lara-Garcia A; Kisseberth WC; London CA; Couto CG
Vet Comp Oncol; 2009 Dec; 7(4):244-55. PubMed ID: 19891695
[TBL] [Abstract][Full Text] [Related]
3. Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats.
Musser ML; Quinn HT; Chretin JD
J Feline Med Surg; 2012 Dec; 14(12):871-5. PubMed ID: 22772480
[TBL] [Abstract][Full Text] [Related]
4. Serum biochemical indicators of hepatobiliary function in dogs following prolonged anaesthesia with sevoflurane or isoflurane.
Yuan Z; Liu J; Liang X; Lin D
Vet Anaesth Analg; 2012 May; 39(3):296-300. PubMed ID: 22405525
[TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs.
Kristal O; Rassnick KM; Gliatto JM; Northrup NC; Chretin JD; Morrison-Collister K; Cotter SM; Moore AS
J Vet Intern Med; 2004; 18(1):75-80. PubMed ID: 14765735
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
Asgarshirazi M; Shariat M; Sheikh M
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
[TBL] [Abstract][Full Text] [Related]
7. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
8. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K
J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305
[TBL] [Abstract][Full Text] [Related]
9. Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital.
Gaskill CL; Miller LM; Mattoon JS; Hoffmann WE; Burton SA; Gelens HC; Ihle SL; Miller JB; Shaw DH; Cribb AE
Vet Pathol; 2005 Mar; 42(2):147-60. PubMed ID: 15753468
[TBL] [Abstract][Full Text] [Related]
10. Biochemical, functional, and histopathologic characterization of lomustine-induced liver injury in dogs.
Dedeaux AM; Flesner BK; Reinhart JM; Langohr IM; Husnik R; Geraci SN; Taboada J; Rademacher N; Thombs LA; Bryan JN; Trepanier LA; Boudreaux BB
Am J Vet Res; 2020 Oct; 81(10):810-820. PubMed ID: 32969725
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers.
Dirksen K; Burgener IA; Rothuizen J; van den Ingh TSGAM; Penning LC; Spee B; Fieten H
J Vet Intern Med; 2017 Jul; 31(4):1017-1027. PubMed ID: 28543991
[TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with the onset of lomustine-induced neutropenia in tumour-bearing dogs.
Treggiari E; Cossu G; Valenti P; Taylor A
Vet Comp Oncol; 2022 Sep; 20(3):577-586. PubMed ID: 35249267
[TBL] [Abstract][Full Text] [Related]
13. CCNU in the treatment of canine epitheliotropic lymphoma.
Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL
J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933
[TBL] [Abstract][Full Text] [Related]
14. Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs.
Chauvet AE; Feldman EC; Kass PH
J Am Vet Med Assoc; 1995 Nov; 207(10):1305-7. PubMed ID: 7591923
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. II. Biochemical and morphological characterization of the injury and its prevention by phenobarbital.
Ahmed AE; Grissom M; el-Azhary R; Haque A; Boor PJ; Costanzi J
Cancer Chemother Pharmacol; 1987; 19(2):103-8. PubMed ID: 3105904
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective and antioxidant effects of the methanolic extract from Halenia elliptica.
Huang B; Ban X; He J; Zeng H; Zhang P; Wang Y
J Ethnopharmacol; 2010 Sep; 131(2):276-81. PubMed ID: 20600758
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
Center SA; ManWarren T; Slater MR; Wilentz E
J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
[TBL] [Abstract][Full Text] [Related]
18. Liver biochemical and histopathological findings in dogs with experimentally induced exocrine pancreatic insufficiency.
Adamama-Moraitou KK; Rallis TS; Papazoglou LG; Papasteriadis A; Roubies N; Kaldrimidou H; Leontides LS
Can J Vet Res; 2004 Jan; 68(1):56-61. PubMed ID: 14979436
[TBL] [Abstract][Full Text] [Related]
19. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
Pari L; Murugan P
Pharmacol Res; 2004 May; 49(5):481-6. PubMed ID: 14998559
[TBL] [Abstract][Full Text] [Related]
20. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
Laprais A; Olivry T
BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
